伴单克隆免疫球蛋白的C3肾小球病是一种独特亚型
5例未获血液学缓解者均无肾脏缓解。
要点
- 50岁以上C3G患者中MIg检出率高达65.1%,提示年龄相关筛查价值。
- C3肾炎因子是最常见自身抗体(45.8%),补体基因致病变异罕见。
- MIg靶向治疗可使部分患者获血液学和肾脏缓解,未获血液学缓解者无肾脏缓解。
核心结论
- 伴MIg的C3G多见于老年患者,C3肾炎因子是最常见自身抗体,MIg靶向治疗可使部分患者获缓解和肾功能稳定。
主要发现
- 36例MIg阳性患者平均诊断年龄60岁,50岁及以上患者中65.1%有MIg。
- C3肾炎因子检出率45.8%,补体蛋白基因致病变异罕见。
- 血液学评估:单克隆肾意义丙种球蛋白血症26例,多发性骨髓瘤5例,冒烟型骨髓瘤2例,慢性淋巴细胞白血病、淋巴瘤或I型冷球蛋白血症各1例。
- 中位随访43.6个月,中位血清肌酐1.4 mg/dL、蛋白尿0.8 g/24h,9例进展至终末期肾病。
关键数值与推荐
- 5例靶向治疗未达血液学缓解者,均无肾脏缓解。
- 17例接受非靶向治疗,3例保守治疗;靶向治疗组多发性骨髓瘤/冒烟型骨髓瘤比例更高,非靶向治疗组单克隆肾意义丙种球蛋白血症比例更高。
临床怎么用
- 对C3G患者尤其是50岁以上者应筛查单克隆免疫球蛋白。
- MIg阳性C3G患者可考虑MIg靶向治疗,血液学缓解与肾脏缓解相关。
局限性
- 为回顾性研究,样本量有限,靶向与非靶向治疗组间疾病构成存在差异,治疗选择可能存在偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Monoclonal immunoglobulins (MIg) may play a causal role in C3 glomerulopathy (C3G) by impairing regulation of the alternative pathway of complement. Ninety-five patients with C3G were tested for MIg of which 36 were positive. Their mean age at diagnosis was 60 years and among patient 50 years and older, 65.1% had a MIg. At presentation, median serum creatinine and proteinuria were 1.9 mg/dL and 3.0 g/24 hours. Hematuria was present in 32 (88.9%) patients. Twelve (34.3%) patients had low C3 levels. C3 nephritic factor was detected in 45.8% patients; pathogenic variants in complement protein genes were rare. Hematologic evaluation revealed monoclonal gammopathy of renal significance in 26 patients, multiple myeloma in five, smoldering multiple myeloma in two, and chronic lymphocytic leukemia, lymphoma, or type I cryoglobulin each in one patient. After a median follow-up of 43.6 months, the median serum creatinine and proteinuria were 1.4 mg/dL and 0.8g/24 hours. Nine patients developed ESRD. Sixteen patients received MIg-targeted treatment, 17 patients received non-targeted treatment while three patients were managed conservatively. Of the 16 patients receiving MIg-targeted treatment, ten achieved complete/very good/partial hematologic response. Of these, seven achieved a complete/partial/stable renal response. Five patients receiving targeted treatment did not achieve hematologic response, none had a renal response. Patients receiving targeted treatment were more likely to have multiple myeloma/smoldering multiple myeloma. Patients receiving non-targeted treatment were more likely to have monoclonal gammopathy of renal significance. Thus, C3G with MIg is seen in older patients, C3 nephritic factor is the most common autoantibody detected, and MIg-targeted treatment may result in remission and stabilization of kidney function in a subset of these patients.
引用
- Ravindran A, Fervenza FC, Smith RJH, et al. C3 glomerulopathy associated with monoclonal Ig is a distinct subtype. Kidney Int. 2018. PMID: 29729982. doi:10.1016/j.kint.2018.01.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。